Post hoc analysis of Ph2 AURA-LV & Ph3 AURORA1 ⬆️VOC-treated pts achieved CRR at 1yr vs. control arm (41.0% vs. 21.9%; OR 2.48, p< 0.0001) and PRR at 1yr (OR 2.3, p< 0.0001) Similar safety profiles VOC: Additional tx option for LN pts w/ UPCR >/=2g/g #ACR23 ABST2326 @RheumNow https://t.co/9z1n3s7umU